← Back to all trials
Completed
NCT04512287
PRP for Treatment of Peyronie's Disease
Conditions: Peyronie Disease, Sexual Dysfunction, Physiological, Sexual Dysfunction Male, Genital Diseases, Male
Sex: Male
Ages: 18 Years – 75 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 65
Sponsor: University of Miami
Location: University of Miami Miami Florida
Summary
The purpose of this study is to learn about the effects of Platelet-Rich Plasma (PRP) injection in men with Peyronie's Disease (PyD).
Eligibility Criteria
Inclusion Criteria:
1. Be Male
2. Be 18 to 75 years of age (inclusive).
3. Be able to provide written informed consent
4. Have a diagnosis of PD with evidence of active or stable disease as determined by the investigator
5. Penile curvature deformity of \>30° to \
Source: ClinicalTrials.gov (NCT04512287). StuddyBuddy aggregates publicly available trial information.
